Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 60 of 348 for:    hepatitis b | Open Studies

Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Taipei Veterans General Hospital, Taiwan
Sponsor:
Collaborators:
Kaohsiung Medical University Chung-Ho Memorial Hospital
China Medical University Hospital
Chi Mei Medical Hospital
Chia-Yi Christian Hospital
Information provided by (Responsible Party):
vghtpe user, Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier:
NCT01491295
First received: October 27, 2011
Last updated: March 31, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)